Global Cardiac POC Testing Devices Market to 2023: High Incidence of CVDs Driving Demand
Dublin, Aug. 14, 2019 (GLOBE NEWSWIRE) -- The "Global Cardiac POC Testing Devices Market 2019-2023" report has been added to ResearchAndMarkets.com's offering.
High incidence of CVDs
Cardiovascular diseases (CVDs) are rising due to a high level of a sedentary lifestyle, smoking, alcohol consumption, high levels of cholesterol in the blood, and diabetes, and others. This has driven the demand for cardiac POC testing devices. Elevated cholesterol levels shoot up the blood pressure.
Cardiac POC testing devices' ability to assess blood glucose and cholesterol levels rapidly has also increased its adoption rate. This demand will lead to the expansion of the global cardiac POC testing devices market at a CAGR of over 6% during the forecast period.
Technological advances in diagnostics
The global cardiac POC testing devices market has witnessed significant developments, owing to factors such as portability of devices, research centers moving to close patent locales, increasing test menus, and rising adoption of multiparameter monitoring devices. The implementation of laboratory functions into portable systems has led to a standard shift in the diagnostics field.
Miniaturization of technology aids in the quantification of living cells on portable systems using small volumes of reagents. This has encouraged several hospitals and clinics across the world to switch from conventional testing methods to POC testing due to its improved efficiency and faster turnaround time. Sensors, microsystems, and low-cost imaging technologies have been developed for POC testing. This development is expected to have a positive impact on the overall market growth.
Market Dynamics
The market report also looks at factors such as high incidence of CVDs, growing diabetic population, emphasis on cardiac marker testing regulatory authorities.
However, product recalls posing a challenge to manufacturers, alternative methods of measuring cholesterol levels, limited access to diagnostic tests in developing countries may hamper the growth of the cardiac POC testing devices industry over the forecast period.
Segment Analysis
The cardiac POC testing devices market analysis considers sales from hospitals and laboratories, diagnostic centers, and ambulatory centers and physicians' clinics. The analysis also considers the sales of cardiac POC testing devices in Asia, Europe, North America, and RoW.
In 2018, the hospitals and laboratories segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as High inflow of patients, expanding the use of medical devices, and growing healthcare expenditure will play a significant role in the hospitals and laboratories segment to maintain its market position.
Competitive Landscape
With the presence of a few major players, the global cardiac POC testing devices market is moderately concentrated. The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading cardiac POC testing devices manufacturers, that include:
- Abbott Laboratories
- bioMerieux S.A.
- Danaher Corp.
- F. Hoffmann La Roche Ltd.
- Siemens Healthcare GmbH
Also, the cardiac POC testing devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
Key Topics Covered
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPE
- Market ecosystem
- Market characteristics
- Market segmentation analysis
PART 04: MARKET SIZING
- Market definition
- Market sizing 2018
- Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
PART 06: MARKET SEGMENTATION BY END-USER
- Comparison by end-user
- Hospitals and laboratories - Market size and forecast 2018-2023
- Diagnostic centers - Market size and forecast 2018-2023
- Ambulatory centers and physicians' clinics - Market size and forecast 2018-2023
- Market opportunity by end-user
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
- Geographic comparison
- North America - Market size and forecast 2018-2023
- Europe - Market size and forecast 2018-2023
- Asia - Market size and forecast 2018-2023
- RoW - Market size and forecast 2018-2023
- Key leading countries
- Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
PART 11: MARKET TRENDS
- Increasing online presence of vendors
- Technological advances in diagnostics
- Advent of wearable devices
PART 12: VENDOR LANDSCAPE
- Overview
- Landscape disruption
PART 13: VENDOR ANALYSIS
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Abbott Laboratories
- bioMerieux S.A.
- Danaher Corp.
- F. Hoffmann La Roche Ltd.
- Siemens Healthcare GmbH
For more information about this report visit https://www.researchandmarkets.com/r/7gg3n3
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900